Previous 10 | Next 10 |
WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that George Elston, Executive Vice President and Ch...
2024-01-22 17:36:05 ET More on EyePoint Pharmaceuticals EyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert Looks Real Deal Shorting EyePoint Pharmaceuticals Ahead Of Davio-2 Wet-AMD Data: Potential 78% Gain Countdown To Clarity: EyePoint's December D...
2024-01-18 16:55:37 ET Gainers: Ventyx Biosciences ( VTYX ) +6% . EyePoint Pharmaceuticals ( EYPT ) +3% . HashiCorp ( HCP ) +3% . Nubia Brand International ( NUBI ) +2% . Microvision ( MVIS ) +2% . Losers: Spectaire...
2024-01-17 06:00:39 ET More on EyePoint Pharmaceuticals EyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert Looks Real Deal Countdown To Clarity: EyePoint's December Data Delivery EyePoint commences $175M stock offering to advance wet AMD therapy into...
2024-01-11 16:37:35 ET Gainers: Ventyx Biosciences ( VTYX ) +6% . EyePoint Pharmaceuticals ( EYPT ) +3% . HashiCorp ( HCP ) +3% . Nubia Brand International ( NUBI ) +2% . Microvision ( MVIS ) +2% . Losers: Spectaire...
WATERTOWN, Mass., Jan. 10, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that the first patient has been dosed in the Phase ...
WATERTOWN, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Execut...
WATERTOWN, Mass., Dec. 08, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the closing of its previously announced underwritte...
2023-12-06 19:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-06 01:37:20 ET More on EyePoint Pharmaceuticals EyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert Looks Real Deal Shorting EyePoint Pharmaceuticals Ahead Of Davio-2 Wet-AMD Data: Potential 78% Gain Countdown To Clarity: EyePoint's December D...
News, Short Squeeze, Breakout and More Instantly...
EyePoint Pharmaceuticals Inc. Company Name:
EYPT Stock Symbol:
NASDAQ Market:
EyePoint Pharmaceuticals Inc. Website:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
2024-05-10 20:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...